Self-limited epilepsy with centrotemporal spikes (SLECTS) …

Epilepsy & Seizures

Updated 08.10.2023
Released 10.18.1993
Expires For CME 08.10.2026

Self-limited epilepsy with centrotemporal spikes

Authors: K P Vinayan MD DM, Arushi Gahlot Saini MD DM MNAMS

See Contributor Disclosures

Editor: Solomon L Moshé MD

Self-limited epilepsy with centrotemporal spikes

In This Article

Quick Link

Introduction

Overview

Self-limited epilepsy with centrotemporal spikes (SeLECTS) is the new name for the previous epilepsy syndrome of benign epilepsy with centrotemporal spikes. It was first reported in the 1950s and is now recognized as the most frequent epilepsy syndrome in children between the ages of 4 and 13 years. The term “benign” was applied to this syndrome to differentiate it from other sinister causes for focal epilepsies. However, cognitive dysfunction, language impairment, and atypical evolutions with adverse seizure and neurodevelopmental outcomes were rarely seen in this syndrome.

The ILAE Task Force report on the nosology and definitions of childhood-onset epilepsy syndromes proposes the terms “self-limited focal epilepsies” of childhood (SeLFE) for focal epilepsies with onset in childhood and “self-limited epilepsy with centrotemporal spikes” (SeLECTS) for Rolandic epilepsy (168). SeLECTS is the most frequent SeLFE and accounts for 6% to 7% of all childhood epilepsies (196). Its incidence is estimated to be 6.1 per 100,000 children below 16 years of age per year (193).

Key points

	• presents with focal seizures with dysarthria, sialorrhea, dysphasia, and unilateral clonic or tonic–clonic movement of the mouth, or nocturnal focal to bilateral tonic-clonic seizures.
	• Seizures commonly occur within 1 hour of falling asleep or 1 to 2 hours prior to awakening.
	• There are high-amplitude, centrotemporal, biphasic epileptiform abnormalities on EEG.
	• There is no developmental regression.
	• Remission occurs by mid- to late adolescence.
	• Specific cognitive, language, memory, and attention-related disorders are increasingly being reported.
	• SeLECTS may atypically evolve into Landau-Kleffner syndrome and epileptic encephalopathy with continuous spike-and-wave activation in sleep (EE-SWAS) with potential for persistent neuropsychological impairments.

Historical note and terminology

The Rolandic (centrotemporal) region is named after Luigi Rolando (1773-1831), an Italian anatomist known for his pioneer research in localization of function in the human brain. A particular EEG pattern with migratory spikes originating over the Rolandic region was first reported in the 1950s (65; 70). In 1958, the first clinical description associated with EEG features was published (132). The same EEG pattern was later correlated with a common form of focal childhood epilepsy, then called "midtemporal epilepsy," characterized by hemifacial and oropharyngeal ictal symptoms and a favorable prognosis (69). Because of the localization of the ictal events, Lombroso proposed the term "sylvian seizures" (121). In the same year, Loiseau and colleagues presented an electroclinical series of 122 children with what they called “a particular form of epilepsy in childhood,” stressing its benign character. Several long-term follow-up studies in the past had confirmed the relatively good prognosis (12; 104; 120). This form of epilepsy was called “benign childhood epilepsy with centrotemporal spikes” and was placed in the group of idiopathic localization-related (focal, local, partial) epilepsies in the International Classification of Epilepsies and Epileptic Syndromes (31; 51).

As new syndromes were recognized within the spectrum of benign childhood focal epilepsies (145), the term “benign” was considered initially acceptable for this syndrome (73). However, the 2017 ILAE Classification of the Epilepsies proposed the term “self-limited” for the “benign” course of epilepsies to reflect a “likely spontaneous resolution of a syndrome” (160). Thus, the new term “self-limited epilepsy with centrotemporal spikes” (SeLECTS) was proposed for this epilepsy syndrome. The word “benign” is sometimes completely omitted to name the syndrome as “childhood epilepsy with centrotemporal spikes” (CECTS) (178). However, the ILAE Task Force on Nosology and Definitions affirms the term SeLECTS for this epilepsy syndrome (168).

Clinical manifestations

Clinical features

Age, sex, and course of illness. The age at onset is typically between 4 and 10 years (range 3 to 14 years) in 90% of patients, with a peak at approximately 7 years. Both sexes are affected, with a slight male predominance (60%). Seizures usually resolve by puberty but can occasionally continue until 18 years of age (18). During the active phase of epilepsy, behavioral and neuropsychological deficits may emerge or worsen, particularly in language and executive functioning, and later improve or resolve. The prognosis for seizure remission is excellent, even for those whose seizures are initially difficult to control (21). The age at seizure onset has been proposed as the most important predictor of early remission, irrespective of the initial EEG findings, antiseizure medication treatment, or seizure frequency (102). Antecedent, birth, and neonatal history; development; cognition; neurologic examination; and head size prior to seizure onset are typically normal. A history of febrile seizures may be seen in 5% to 15% of cases. Preexisting attention-deficit/hyperactivity disorder and specific cognitive function deficits may occur (140). SeLECTS may be seen in children with a history of prior neurologic injury or intellectual disability, but these features are considered coincidental and not causal.

Ictal phenomenon. Focal seizures with characteristic frontoparietal opercular features or nocturnal bilateral tonic-clonic seizures are mandatory for diagnosis.

The characteristic semiology of the focal seizures includes the following (168):

(1) somatosensory symptoms, with unilateral numbness or paresthesia of the tongue, lips, gums, and inner cheek.

(2) orofacial motor signs, specifically tonic or clonic contraction of one side of the face, mouth, and tongue, then involving one side of the face. In nocturnal seizures, the initial focal component may often not be witnessed.

(3) speech arrest; children have difficulty or are unable to speak (dysarthria or anarthria) but can understand language.

(4) sialorrhea, a characteristic ictal symptom. It is unclear whether this is due to increased salivation, swallowing disturbance, or both.

(5) In seizures associated with SeLECTS, cognitive (eg, gustatory hallucinations), emotional (eg, fear), and autonomic features are not seen.

The initial event is often a nocturnal hemifacial convulsion, which may rapidly evolve to tonic-clonic activity of the ipsilateral upper limb, to an ipsilateral hemiclonic seizure, or to a focal to bilateral tonic-clonic seizure. Seizures are typically brief, lasting for 1 to 3 minutes. More than half of the patients retain consciousness and may recollect the sensations. Seizures occur in sleep in the great majority (80% to 90%) of patients, and only while awake in up to 20% of children (36). Todd paresis may occur postictally. Miscellaneous symptoms, such as abdominal pain, may rarely occur (12). Among 230 children with SeLECTS, six presented with sensory motor seizures in the leg as the main ictal manifestation (61). Generalized tonic-clonic seizures during wakefulness are exclusionary and should prompt one to review the diagnosis.

This is associated independently with bilateral, repetitive, broad, centrotemporal interictal EEG spikes displaying a characteristic tangential bipolar pattern (72). The ictal manifestations are not indicative of temporal lobe involvement and the term “centro-temporal” refers only to the spike topography.

Recurrence of seizures. Onset before 3 years of age has been stated as the single most important predictor for multiple seizures (98; 205). Neither clinical features, seizure characteristics, nor routine EEG findings were found to be useful in predicting the likelihood of a second seizure in SLECTS (191). However, in a longer follow-up study of 52 children, the presence of a frontal focus and bilateral asynchrony were found to be correlated with the recurrence of seizures (175). The occurrence of atypical absence seizures, focal atonic seizures, and focal motor seizures with negative myoclonus with loss of balance and falls should suggest evolution to EE-SWAS, and evidence of cognitive impairment or regression should be sought.

Associated problems

Behavioral problems. Behavioral disorders may be present in approximately one third of patients with SeLECTS, including ADHD and oppositional defiant disorder (141). Early onset of seizures and the presence of bilateral interictal epileptiform discharges may suggest an increased risk for behavioral disorders in these children.

Cognitive problems. Cognitive problems and low academic achievement might be seen in children with SeLECTS. In a study of 40 children with centrotemporal spikes with and without seizures compared with 40 healthy controls, patients were significantly impaired in intelligent quotient (IQ), visual perception, short-term memory, and psychiatric status. The deficits in IQ correlated more with the frequency of spikes in the EEG than with the frequency of seizures (192).

Another study of 50 children identified educational problems in 54%, developmental learning disability in 38%, expressive language impairment in 18%, and attention disorders in 18% of the cases. The educational problems correlated significantly with the absence of a frontocentral dipole in the EEG (p < 0.001) whereas the abnormal language functions correlated significantly with atypical seizure semiology (p = 0.02) (187). The impact of SeLECTS on school performance was demonstrated in another study of 40 cases and controls (130). The patients showed lower scores in academic performance, digits and similarities subtests of WISC, and auditory processing subtests, probably due to executive dysfunction. Impaired social behavior (especially on “theory of mind tasks”) was found in 15 children (67).

Children and adolescents with SeLECTS had worse performance on social cognition compared to healthy children as evaluated by Faux-Pas Child Task, which evaluates the recognition and comprehension of other people’s mental state (114). Patients with SeLECTS also demonstrate processing speed dysfunction (111).

Language skills. A meta-analysis of 22 studies on literacy and language skills in children with SeLECTS showed the presence of reading and phonological processing deficits highlighting the need for early literacy and language assessment (166). Atypical evolution of the seizures and a longer duration of epilepsy may influence the language skills of these patients. Thirty-one patients with clinical and electroencephalographic diagnosis of SeLECTS and 31 paired normal children underwent a language and neuropsychological assessment performed with several standardized protocols. Findings showed significant dyslexia in patients with SLECTS (137). Risk factors for reading and phonological disorders were evaluated in an observational study of 108 probands with this epileptic syndrome and their 159 siblings: reading disorder was reported in 42% of probands and 22% of siblings (185). Seizure or treatment variables did not appear to be important risk factors for the reading disorder. The association between higher spike-wave index during NREM sleep and poorer nonverbal declarative memory consolidation supported the hypothesis that interictal epileptic activity could disrupt sleep memory consolidation (62).

A systematic review of studies published between 2005 and 2016 on language skills in children with SeLECTS concluded that children had language skill disorders in the receptive and productive domains of semantics, morphosyntax, imitations in the intrasyllabic, syllabic, and phonemic levels, and deficits in verbal fluency (semantic and phonemic) and in verbal memory (176). Another systematic review of 43 studies (1179 patients and 1086 healthy controls) on executive functioning in children with SeLECTS concluded that children with SeLECTS show weaker performances in inhibitory control, cognitive flexibility, and verbal fluency when compared with a control group (150). However, because the quality of evidence was classified as very low, caution is needed when interpreting the strength of the results.

Other problems. Spectral resolution is the ability needed for complex listening tasks, such as understanding speech in the presence of background noise, and has a significant role in children, particularly in classroom learning. A study on the auditory spectral resolution abilities of children with SeLECTS using the spectral temporally modulated Ripple test showed that the auditory spectral resolution threshold measured was significantly lower when compared to controls (170).

Children with SeLECTS show altered functional connectivity associated with speech production between the left precuneus and the right cerebellum, between the right precuneus and the bilateral thalamus and the left superior temporal gyrus, between the right cuneus and the right postcentral gyrus and the right inferior parietal lobule, and between the right cerebellum and the right middle frontal gyrus, suggesting an abnormal functional connectivity basis of speech production (200).

A study of 74 children with SLECTS showed significant oral dyspraxia in these children as compared to children without epilepsy, particularly in simple and sequenced movements (13). This was attributable to the genetically determined immaturity of cortical structures related to motor planning in children with SLECTS.

A neuropsychological comparative study in 33 recently diagnosed patients with SLECTS and 33 patients with SLECTS after complete remission showed that the newly diagnosed patients with SLECTS exhibited emotion discrimination dysfunction, mainly related to sadness, fear, and disgust, using the Eye Basic Emotion Discrimination Task and the Eye Complex Emotion Discrimination Task (199). This dysfunction was more severe in children with an earlier onset of seizures. However, after epilepsy remission, the ability to discriminate emotions returned to normal.

A study comparing the functional integrity of verbal working memory neural networks in SLECTS with healthy controls using functional magnetic resonance imaging (fMRI) showed that the behavioral performances during working memory tasks, in particular accuracy and response time, were poorer in children with SeLECTS than in controls (28).

Central auditory processing disorder was noted in 46% of patients with SeLECTS and without intellectual disability, dyslexia, and attention-deficit hyperactivity disorders (124).

Atypical features have been noted in up to 50% of the patients with SeLECTS (195; 39):

	• Earlier age of onset of seizures (< 3 years and more than 14 years of age)
	• Daytime seizures only
	• Usual seizure frequency more than daily
	• Focal motor or generalized convulsive status epilepticus >30 min
	• Moderate to profound intellectual disability
	• Poor neuropsychological outcomes
	• Hemiparesis or focal neurologic findings, other than Todd paresis
	• Causal lesion on brain MRI
	• Lack of sleep activation of centrotemporal abnormalities
	• Persistently unilateral centrotemporal abnormalities on serial EEGs
	• Unusual spike morphology and distribution or sustained focal slowing without centrotemporal spikes or diffuse slowing on EEG
	• Absence-like spike-and-wave discharges

In children with SeLECTS, presence of atypical features in the early EEGs, such as slow spike-wave focus, synchronous foci, or generalized 3 Hz spike-wave discharges, predicted lower full-scale IQ and verbal IQ and impairments in some tasks of the performance scale (125).

In a retrospective, multicenter study of 46 patients with atypical features in SeLECTS, the predominant manifestations were seizures with affective symptoms (28.2%); seizures with unilateral facial sensorimotor symptoms; oropharyngolaryngeal manifestations; speech arrest with sialorrhea only when awake (24.8%); opercular epileptic status with unilateral or bilateral clonic seizures of the mouth, with speech arrest and sialorrhea when awake and during sleep (15.3%); postictal Todd paralysis after unilateral clonic seizures (15.3%); negative myoclonus (13%); focal sensorimotor seizures characterized by unilateral numbness in the cheeks and one upper limb, additional to unilateral facial clonic seizures, speech arrest, and sialorrhea (2.1%); and sporadic focal tonic-dystonic seizures in the left upper limb only during sleep (2.1%) (63).

Atypical evolution accounts for around 5% of patients with SeLECTS in most of the tertiary epilepsy centers for children. Early onset of SeLECTS, neurocognitive regression with a continuous spike-and-wave pattern in sleep (suggests EE-SWAS), appearance of new seizures such as atypical absences or negative myoclonus, increased frequency of fronto-centro-temporal EEG focus in both sleep and wakefulness, and presence of more than five ripples on the centrotemporal spikes are predictive of atypical development (184; 146).

Atypical SeLECTS showed more widespread and severe hypometabolism than typical SeLECTS, mainly located in the fronto-temporo-parietal cortex (109).

Notable risk factors proposed to predict atypical evolutions are frontotemporal and temporo-parietal localization of epileptic foci, semiology of seizures involving dysarthria, and somatosensory auras in the early presentation of the disease (149).

Prognosis and complications

In general, SeLECTS is associated with an excellent prognosis.

Seizures. The majority of children have infrequent seizures, which are well controlled with the initial antiseizure medication. The prognosis is favorable even for those whose seizures are difficult to control, and seizures almost always remit spontaneously in late adolescence.

Cognitive functions. Most of the children have normal cognitive functions during the period of active epilepsy and after remission (80). Microstructural changes in cortex and white matter were described in some previous studies, the clinical significance of which is not clear (92; 64).

Language impairment. Moderate to severe language impairment has been reported in some children, especially in expressive grammar, phonologic awareness, and literacy skills (134). Persistent deficits in children after seizure remission suggested possible long-term consequences (131). Abnormal neuropsychological development significantly correlated with a greater frequency of NREM sleep discharges, epilepsy onset at school age, and a higher number of antiepileptic drugs (58).

Attention deficit hyperactivity disorder (ADHD). The prevalence of ADHD may be up to 65%, and patients perform poorer on executive and attentional tasks (113; 38). This has been related to thinner superior-inferior frontal cortex, superior temporal cortex, left pericalcarine, and lingual and fusiform cortex compared to healthy controls (90). A study of 42 patients with newly diagnosed SeLECTS evaluated the long-term prognosis of attention deficit in children (over a period of 7 years) and showed impaired attention network, mainly in the alerting and orienting domains (198).

Atypical evolutions. Most of the children with atypical evolutions will also have a good long-term prognosis (Aicardi and Chevrie 1982; 57; 55; 20). However, Landau-Kleffner syndrome and EE-SWAS may portend permanent language dysfunction or neuropsychologic involvement (53; 55; 56).

Antiseizure medication therapy. Antiseizure medication therapy does not necessarily improve and may actually decrease health-related quality-of-life in SLECTS children with low seizure frequency (04).

Transition. SLECTS almost always enters terminal remission before the general age of a planned transition of adolescents (21).

Biological basis

Etiology and pathogenesis

Over the years, our understanding of the genetic basis of SeLECTS has significantly evolved. The characteristic centrotemporal pattern in SeLECTS was initially considered an autosomal dominant trait with variable penetrance based on monozygotic twin studies (78; 50; 10). Later, a multifactorial pathogenesis of epilepsies with focal epileptiform sharp waves was considered (46). In a multicenter twin collaboration study analysis of the etiology of SeLECTS, no concordant twin pairs with the classic form of this syndrome were found in the 18 pairs identified, suggesting that noninherited factors are of major importance in the etiology (182). The atypical evolution of SeLECTS may have a more complex inheritance than a simple monogenic pattern (180).

SeLECTS has subsequently been linked to chromosome 15q14, terminal deletions of the long arm of chromosome 1q, chromosome 11.p13, polymorphisms in elongator protein complex 4 (ELP4) and brain-derived neurotrophic factor (BDNF), deletions in 16p13, and mutations in GRIN2A, PRRT2, KCNQ2/3, DEPDC5, NR4A2, CHRNA4, ZMYND11RBFOX1/3, and GABRG2) (103; 44; 71; 153; 48; 151; 133; 49; 81; 135).

GRIN2A has been identified as the major gene in epileptic encephalopathies. The role of GRIN2A mutations in SeLECTS, especially in severe phenotypes, has been highlighted in recent studies. With the advent of advanced genetic techniques, genome-wide studies are highlighting rare associations of SLECTS with deletions in chromosomes 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 14, 15, 16, 17, 18, 19, and 20 that overlap with the known autism- and epilepsy-associated candidate genes (86). Similar associations have been seen with multiple single nucleotide polymorphisms in regions on chromosomes 3, 15, and 10 located in or nearby the genes KALRN, CHRNB4, and PTCHD3/RAB18, respectively (164). Environmental risk factors, such as maternal smoking around birth, have also been implicated in the pathogenesis of SLECTS (164). A trios-based whole-exome sequencing study in 28 Chinese patients with typical and atypical SLECTS showed an association with the genes ADGRV1, GRIN2B, and RyR2 (118). As these genes are all calcium homeostasis–associated genes, they suggest a potential effect of calcium homeostasis in the epilepsy.

Pathophysiology

Several neurobiological hypotheses have been put forward in SeLECTS Sylvian and rolandic areas. The typical focal, ictal clinical behavior and EEG discharge indicate a disturbance in the sylvian and rolandic areas. SeLECTS, Landau-Kleffner syndrome, and continuous spike-and-waves during slow sleep syndrome are often considered as a spectrum of disorders with a common transient, age-dependent, nonlesional, genetically based epileptogenic abnormality, implying the role of a perisylvian epileptic network where the cognitive impairment is caused by epileptic discharges interfering with cognitive development (77).

Involvement of larger brain areas. Electrophysiologic studies fail to demonstrate a discrete generator, and it is suggested that a large, shifting area of dysfunction may be present, including the deep brain structures, such as the cingulate gyrus, basal ganglia, and thalamus, based on hemodynamic responses in these areas with centrotemporal spikes (85). In some SeLECTS patients, the occurrence of generalized spike-wave EEG discharges, as well as focal spikes in other areas, suggests a relationship between this disorder and the idiopathic generalized epilepsies, as well as with other idiopathic focal epilepsies (105). Around 20% of patients with centrotemporal spikes may also have sharp slow wave complexes in other cortical locations (144).

Thalamocortical circuitry. Because SeLECTS presents during a specific age group when significant diffuse white matter maturation in the brain is going on and has a dramatic activation with non-REM sleep, a role of aberrant thalamo-cortical circuits has been postulated (101). It has been demonstrated that the epileptiform spikes can be triggered and promoted by either a reduced NMDA current or h-type current, and changes in inhibitory transmission in the thalamic reticular nucleus mediate an antagonistic dynamic between epileptiform spikes and spindles in patients with SLECTS (107).

Patients with atypical evolution of SeLECTS show a symmetric hypoperfusion at the level of thalamus in interictal SPECT without structural abnormalities on MRI and increased risk of cognitive deficits (06). A study compared the EEG sleep findings in 30 children with SeLECTS with 20 age-matched healthy controls and found significantly lower mean values of the amplitude, duration, and density of the spindle activity in patients with SeLECTS (157). Additionally, the risk of epilepsy was found to increase by 1.9% by the decrease of the mean amplitude of the spindles by 1 mV when compared to control group. Paucity of sleep spindles in the Rolandic cortex and adjacent areas has been noted during the active phase of epilepsy. Because spindles are generated in the thalamus and amplified through regional thalamocortical circuits, it has been hypothesized that regional spindle deficits predict cognitive function (169). These findings suggest an underlying pathophysiologic mechanism for thalamocortical oscillations and functional and structural thalamocortical circuit disruption in SeLECTS (99). A comparative brain tractography study of 23 children with SeLECTS aged 8 to 15 years and age-matched controls showed that children with SeLECTS had aberrant development of thalamocortical connectivity to the rolandic cortex, absence of an expected increase in connectivity with age, and persistence of abnormalities over time when observed longitudinally (178).

Neurodevelopmental origin. A neurodevelopmental origin of SeLECTS has been proposed based on a systematic review of MR imaging studies, suggesting that the development of regions of the cortex in children with this epilepsy is abnormal, more widespread, and due to neurodevelopmental delay rather than apparent "damage" from the epilepsy (167). Children with SeLECTS have been shown to have delayed brain development, with alteration in gray matter and white matter volumes in the brain, specifically in the rolandic regions, and a 0.45-year delay in brain age in contrast to children with typical development (156). A delayed cortical maturation at the centrotemporal brain regions has been proposed based on the comparison of resting-state brain activities by quantitative EEG in 16 SeLECTS patients with clinical seizure remission stage in comparison with healthy controls (165). According to a brain age prediction model (BAE NET) based on structural MRI brain data from normal children with typical development, children with SeLECTS showed imaging phenotypes of delayed brain development, with increased grey matter volume and decreased white matter volume in the rolandic regions. The children with SeLECTS also had a 0.45-year delay of brain-predicted age compared to normal children. Delayed brain age was associated with morphometric changes in the rolandic regions as well as deficits in attention on formal testing (207). A study based on cortical surface-based morphometry in 25 patients with SeLECTS showed that there is aberrant cortical thickness, cortical gyrification, and sulcal depth in areas related to cognitive functions, including language, attention, and memory (112). There was a negative correlation between age of onset of seizures and cortical thickness and cortical gyrification, as well as between verbal IQ and cortical gyrification in these areas. This correlation between some brain regions and verbal IQ and age of onset may suggest a potential marker of early neurodevelopmental disturbance and cognitive dysfunction in SLECTS.

A protocol has been proposed for an ongoing multicentric study on the connectome-based predictive modeling for predicting brain age in patients with SeLECTS (188). This is a machine-learning approach that uses whole-brain connectivity measured with neuroimaging data ("neural fingerprints") to predict brain-behavior relationships.

Differential diagnosis

Confusing conditions

The presence of the characteristic centrotemporal spikes alone is not diagnostic of SeLECTS. These may be seen in children without seizures as well as in nonepileptic children with diffuse brain disturbances, such as cerebral palsy (148) and Rett syndrome (154).

SeLECTS is the most common epilepsy syndrome, seen in patients with fragile X syndrome, and centrotemporal spikes may be present as an asymptomatic finding (91).

DEE-SWAS or EE-SWAS. Patients with DEE-SWAS may present with similar seizures but can be distinguished by cognitive and language regression. Children with SeLECTS may rarely evolve to this syndrome.

Focal seizures due to structural brain abnormality. Distinction between SeLECTS and structural focal epilepsies, such as mesial temporal lobe epilepsy, can usually be made easily on the basis of history and the unique dipole pattern of the centrotemporal spike. The EEG alone is sufficient to make the diagnosis of SeLECTS when nocturnal convulsions are the presenting complaint, and a generalized epileptic syndrome is initially suspected.

Other self-limited focal epilepsies. The morphology of the EEG abnormalities in the various self-limited focal epilepsies may overlap, and their seizure localization may change with age. If patients present with prolonged focal nonmotor seizures with prominent autonomic features, especially ictal vomiting, self-limited epilepsies with autonomic seizures should be considered.

Associated or underlying disorders

Fortuitous associations may be found between SeLECTS and static brain lesions with epilepsy (158). Reported examples are unilateral opercular neuronal migration disorders (03; 53; 162), cerebral tumors (163), neuronal migration disorders and gliosis (139), and hippocampal sclerosis (142).

Pathophysiologic relationships may exist between SeLECTS and SeLFEs, which can make differential diagnosis difficult. The coexistence of two types of SeLFEs in children has been reported, either presenting in sequence one after the other or at the same time (143; 23; 32; 24; 26). The coexistence of childhood absence epilepsy and SeLECTS was detected in 11 patients through a systematic record review from eight epilepsy centers (186). A comparison of 17 patients with absence epilepsy and centrotemporal spikes with age-matched 90 children with absence epilepsy showed significantly more global developmental (5 [29%] vs. 5 [6%], P < .009) and expressive language (4 [24%] vs. 5 [6%], P < .034) delay, and more difficulties with school performance (11 [65%] vs. 32 [36%], P < .025), especially with language-related tasks (6 [35%] vs. 5 [6%], P < .001) in children with absence epilepsy and centrotemporal spikes (40).

An interesting association with migraine has been proposed in patients with SeLECTS (16). In a comparative cohort of children with SeLECTS, with cryptogenic/symptomatic partial epilepsy and with no history of seizures (n = 53 each), a higher rate of migraine was identified in focal epilepsy, regardless of the etiology (197). Another study of 72 children with SeLECTS and their siblings showed that prevalence of migraine was 15% in epilepsy probands versus 7% in nonepileptic controls (29). Prevalence of migraine was 14% in siblings of SLECTS and 4% in siblings of controls.

Diagnostic workup

EEG

Characteristics of EEG spikes in SeLECTS
	• Background activity is typically normal, with normal sleep architecture. If sustained focal slowing without centrotemporal spikes or diffuse slowing is recorded, another epilepsy syndrome or a structural lesion should be considered, and brain imaging is recommended. A change in morphology, particularly the appearance of focal fast spikes or polyspikes, or a marked increase in the slow component, or a brief depression of voltage may suggest the possibility of a focal lesion (37).
	• High-amplitude (> 200 μV, peak to trough) centrotemporal sharp-and-slow-wave complexes that activate in drowsiness and sleep are mandatory for diagnosis (79). They are triphasic, high-voltage (100–300 µV) sharp waves (initial low-amplitude positivity, then high-amplitude negativity, followed again by low-amplitude positivity), with a transverse dipole (frontal positivity, temporoparietal negativity), often followed by a high-voltage slow wave.
	• The abnormalities may be isolated or occur in trains of doublets and triplets, and focal, rhythmic, slow activity is occasionally observed in the same region as the spikes (129).
	• Spikes may be unilateral or bilateral and independent or synchronous and may be seen outside the centrotemporal region (midline, parietal, frontal, occipital). Generalized 3 Hz spike-and-waves and focal spikes in other brain areas may also be seen in a minority of children (15).
	• The centrotemporal spikes are not enhanced by eye opening or closure, by hyperventilation, or by photic stimulation. Hyperventilation may even reduce the frequency of rolandic spikes (190). They may be activated by sensory stimulation of the fingers or toes in 10% to 20% cases (42).
	• Ictal recordings are rare and may be accompanied by a brief decrease in amplitude of the background EEG, followed by diffuse sharp wave abnormalities of increasing amplitude, predominantly in one centrotemporal region, followed by high-amplitude slowing and then a return to the usual interictal EEG (161).
	• With focal to bilateral tonic-clonic seizures, ictal rhythms may become bilaterally synchronous (as opposed to generalized) sharp wave or spike-and-wave activity (02).

There is no correlation between the burden of spike discharges on EEG and frequency, length, or duration of clinical seizures (104). In fact, extreme discrepancies between the rarity of seizures and the activity of the EEG foci are not uncommon, and clinical experience indicates that the EEG is often relatively unchanged, even with effective treatment (08).

Dipolar pattern in SeLECTS. Several authors emphasized the characteristic dipolar pattern in EEG (72; 115; 181). According to EEG findings, two groups of patients have been noted: (1) a high-central region group with more frequent hand involvement and (2) a low-central group with common orofacial symptoms. Electroencephalographic spike source dipoles of centrotemporal spikes were analyzed in 37 patients (93). Differences in spike source dipole were found in patients showing atypical outcomes.

Newer techniques for EEG analysis. An algorithm for automatic classification of centrotemporal spikes in the interictal EEG according to the epilepsy type has been proposed and may distinguish benign from symptomatic causes (127). A novel machine-learning model that efficiently distinguished rolandic seizures from normal EEG signals has been proposed, with an accuracy exceeding 97.6% (123). This proposed machine-learning model processes the identification procedure in the following order: (1) creating preliminary EEG features using signal empirical mode decomposition, (2) applying weighted overlook graph, and (3) classifying the results through a 2-dimensional convolutional neural network. A novel SeLECTS spike detection algorithm based on time domain EEG sequence features and the long short-term memory neural network has been proposed to aid in the automated detection of rolandic spikes, with a sensitivity of 92.04% and precision of 85.75% (203).

Spike ripples have been identified as a promising new biomarker of epilepsy in noninvasive EEG studies (59). Ripples on centrotemporal spikes are considered to indicate epilepsy severity. The absence of ripples predicts a relatively benign clinical entity (184). A study proposed that spike ripples (ripples cooccurring with epileptiform discharges) have a comparable sensitivity and negative predictive value, but greater specificity and positive predictive value, as compared to spikes alone in predicting seizure risk in children with SeLECTS (96). A comparative study of seven patients with atypical SeLECTS and 18 patients with typical SeLECTS in the secondary bilateral synchrony and non-secondary bilateral synchrony periods found that ripples were enhanced when interictal epileptiform discharges were bilaterally synchronized in patients with atypical SeLECTS (83). The study highlighted the distinction between atypical and typical SeLECTS with ripple distribution in the non-secondary bilateral synchrony period.

Intrahemispheric cortico-cortical EEG functional connectivity (EEGfC) was explored in 17 nonmedicated children with SeLECTS and 19 controls, and the areas of increased EEGfC corresponded to cortical areas related to speech and attention deficits (30).

A nonlinear analysis, including measures such as multiscale entropy and recurrence quantitative analysis, of visually normal EEGs has been used to differentiate between patients with and without SeLECTS (159).

Spike clearance velocity. Spike clearance velocity (defined as a decrease in the spike-wave rate over time in 4-year sequential follow-up EEGs) has also been suggested as an EEG marker to guide antiseizure medications in children with SeLECTS (177). The study cohort consisted of 127 children with SeLECTS divided into three groups based on antiseizure medication responsiveness: group I was seizure-free with monotherapy (n: 61, 48%); group II was seizure-controlled with monotherapy (n: 52, 41%); and group III was seizure-controlled with dual therapy (n: 14, 11%). The authors found no statistical significance across the study groups with respect to initial EEG spike characteristics (spike-wave rate, spike localization, and spike topography). However, the spike clearance velocity was significantly slower in group III than in group I in 4-year sequential follow-up EEGs. Further, the spike clearance velocity was not different across the antiseizure medication groups (oxcarbazepine, valproic acid, and levetiracetam).

Magnetoencephalographic analysis. MEG-based studies in patients with centrotemporal spikes in SeLECTS suggest that these discharges are generated through a mechanism similar to that of somatosensory evoked responses (126). An MEG-based study of 33 children with SeLECTS and 18 healthy children showed magnetic source inactivation of the medial frontal cortex and posterior cingulate cortex regions during the interictal time, possibly accounting for the cognitive decline in early untreated children with SeLECTS (110). The magnetic source localization in the 4 to 8 Hz frequency band may be a new imaging marker for the diagnosis of new SeLECTS and cognitive impairment via identification of disordered networks (108).

Brain MRI

Structural abnormality. Typically, MRI is normal and is not required for the electroclinical diagnosis of the syndrome. Nonspecific MRI findings, such as hippocampal asymmetry, white matter abnormalities, and enlargement of the lateral ventricles, should not exclude a diagnosis of SeLECTS. Focal cortical dysplasia and tumors have presented with the clinical and EEG phenotype of SeLECTS (03; 53; 163; 162). Patients with focal epilepsy due to structural abnormalities, such as focal cortical dysplasia, heterotopia, or low-grade brain tumors, may mimic SeLECTS but usually show atypical features, such as unilateral EEG abnormality or drug resistance (168). In 171 consecutive patients with this syndrome studied with CT or MRI, 10 children were noted to have neuroimaging abnormalities (66).

Volumetric changes. Frontal and prefrontal volumes revealed growth disturbances in patients with cognitive impairments (189). Thickness of the corpus callosum has been suggested as a new radiologic biomarker for predicting first antiseizure medication response and seizure recurrence in SeLECTS patients (43). Thicknesses of genu and isthmus were significantly reduced in the SeLECTS group compared to healthy controls, and the total number of seizures negatively correlated with the thickness of the body, isthmus, and splenium (p < 0.001), thus, working as a protective mechanism to prevent seizure spread to other brain regions.

Positron emission tomography

Positron emission tomography is not routinely performed in these children. It may be helpful to distinguish SeLECTS from symptomatic cases of focal epilepsy in children (183). Focal cortical hypermetabolism in the central cortex was noted in three children with atypical SeLECTS during the seizure-free period (33), suggesting a localized, increased cortical activity, likely due to either subclinical seizure activity or “active” inhibitory (GABAergic) processes.

Functional MRI (fMRI)

Several fMRI studies have been reported in SeLECTS. It is increasingly being used to study the dynamic alternations in networks in SeLECTS (206). Aberrant functional connectivity between motor and language networks, abnormal intrahemispheric segregation, and interhemispheric integration has been seen in these children (14; 204). Another fMRI study of 26 children with SeLECTS showed aberrant dynamic regional interplay in sensorimotor, linguistic, and lateral temporal regions, which may affect cognitive performance in these children (87). Resting state fMRI studies in a smaller number of patients with SeLECTS (n=12) show normal cortical-subcortical functional connectivity with compensatory hyperconnectivity between cortical networks caused by widespread cortical abnormal discharges and might account for the self-limited clinical outcome in SeLECTS (60). A “granger causality density” method has been proposed as an effective and reliable neuroimaging biomarker to localize the interictal focus of SeLECTS and make an early diagnosis (35).

Transcranial magnetic stimulation

A pilot study proposed the use of transcranial magnetic stimulation paired with EMG and EEG to measure the trajectory of cortical excitability in children with SeLECTS and to assess whether motor cortex plasticity correlates with learning ability (11). Resting state functional MRI analysis has shown an association between centrotemporal spikes and earlier hemodynamic activations in epileptogenic regions in SeLECTS that were counteracted by levetiracetam treatment (202). A small open pilot study of four SeLECTS patients who had frequent seizures (at least three seizures during the 3-month baseline) found a beneficial role of low-frequency repetitive transcranial magnetic stimulation (1 Hz with 500 pulses at 90% of resting motor threshold for 10 weekdays) in reducing clinical seizures after localizing sources of interictal epileptiform discharges with magnetoencephalography (88).

Other investigational techniques

An excitatory and inhibitory imbalance in neural networks has been suggested as a useful diagnostic biomarker for SeLECTS using a resting-state dynamic causal modeling-based support vector machine (rs-DCM-SVM) algorithm, with an accuracy of 81% to 88% (34).

Management

SeLECTS is an age-related syndrome that almost always disappears by adolescence, regardless of age at onset; therefore, excessive restriction of activities and overprotection of affected children are not advised. Drug therapy is necessary only if there are very frequent seizures. Focal motor seizures, a short interval between the first and second attack, and an early onset usually indicate the necessity of treatment.

Monotherapy should be used whenever possible. In a Cochrane systematic review, the seizure-free rates were 64% for carbamazepine, 67% to 70% for clobazam, 67% to 89% for oxcarbazepine, 86% to 100% for levetiracetam, 69% for topiramate, and 68% to 90% for sulthiame (174). A systematic review of seizure-freedom rates in patients with SeLECTS receiving antiseizure medication suggested the use of sulthiame, levetiracetam, or clobazam as first-line agents for the treatment of SeLECTS in children (68). Another systematic review of randomized controlled studies between 1990 and 2021 indicated some discrepancies in efficacy and tolerability among antiseizure medications used in patients with SeLECTS. More randomized controlled trials comparing antiseizure medications with larger populations are required to ascertain the optimum antiepileptic drug treatment to guide clinicians.

Antiseizure medication treatment

Carbamazepine and valproic acid were traditionally the drugs of choice for this syndrome. Levetiracetam monotherapy has gained attention as a probable alternative. In a comparative study of carbamazepine, valproic acid, and levetiracetam in 89 patients, the maximum response rates were with levetiracetam (71%), followed by valproic acid (56%) and carbamazepine (11.2%) (89). However, better response rates have been noted for carbamazepine—up to 64% during the first year of treatment in a Cochrane meta-analysis (174). The results of the pooled analysis in a systematic review indicated that levetiracetam did not demonstrate a higher probability of seizure freedom than carbamazepine [RR = 1.25, 95% CI (0.52, 2.99)] (27). In a comparative trial of 56 patients with SeLECTS, the seizure-freedom rates were similar between levetiracetam and valproic acid monotherapy groups, but a greater number of the children taking valproic acid achieved EEG normalization (95% vs. 72% with levetiracetam at 18 months) (201). However, valproic acid use in adolescent females is of concern due to hormone abnormalities, obesity, and polycystic ovarian syndrome. A meta-analysis of 49 studies from 2000 to 2018 suggested that levetiracetam, as an initial antiseizure medication, was superior to carbamazepine for cognitive protection (09). Levetiracetam inhibited centrotemporal spikes-associated activation intensity and altered its temporal pattern. It also affected the brain deactivation related to higher cognition networks (208). Children administered levetiracetam showed a mild but statistically significant improvement in overall cognitive abilities, verbal skills, visual-perceptual reasoning, working memory, and processing speed as compared to the control group (children with specific learning disabilities) at 2-year follow-up (138).

Oxcarbazepine monotherapy was found to be more effective and associated with higher improvements in intelligence and cognitive function than levetiracetam monotherapy in children with SeLECTS (172). A multicentric study of 1817 Chinese children demonstrated that oxcarbazepine, levetiracetam, and valproic acid could be used as first-line drugs, and the efficacy of oxcarbazepine and levetiracetam was higher than that of valproic acid (117). In a retrospective study of 430 patients with centrotemporal spikes, the comparative efficacy of levetiracetam, oxcarbazepine, and valproic acid evaluated over a 2-year follow-up was similar (74). On meta-analysis of published randomized studies, no significant difference between levetiracetam, oxcarbazepine, and valproic acid was noted for seizure freedom rates (27).

Benzodiazepine treatment for several weeks was also recommended (41). In comparison with valproate and carbamazepine, clonazepam showed to be more efficient in making rolandic discharges disappear after 4 weeks of treatment (128). The use of clobazam at night may be considered in those children who only have seizures during sleep (54). A prospective controlled study of clobazam versus carbamazepine in patients with frequent seizure episodes showed that clobazam in monotherapy was as effective as carbamazepine and better tolerated (05); however, the quality of evidence was low.

Sulthiame was recommended in several reports (45; 106). In a double-blind, placebo-controlled study of 66 children, sulthiame was found to be remarkably effective in preventing seizures and was well tolerated (152). It has been considered as the drug of choice in patients presenting with atypical evolutions associated to secondary bilateral synchronies in the EEG (55; 54). A noninferiority study comparing levetiracetam to sulthiame in 43 patients with SeLECTS showed that the rates of seizure-free patients were relatively high in both groups, although termination of drug treatment due to seizure recurrence or adverse events occurred more frequently in the levetiracetam group compared to sulthiame group (17). Another randomized controlled trial to compare the effects of levetiracetam and sulthiame on EEG in 43 children with SeLECTS showed similar reductions in the spike-wave-index with both the drugs (173).

In a monotherapy trial of topiramate (116), the drug was orally administrated once a night (2 mg/kg/day) and twice a day (4 mg/kg/day) in 85 patients with SeLECTS. There was no significant difference in overall efficacy rate or changes in EEG activity between the two groups but the rate of adverse reactions for night dose was significantly lower than daytime dosing group, suggesting the former as a feasible strategy for the treatment of SeLECTS.

In a retrospective study of 120 patients who were randomly treated with lamotrigine, oxcarbazepine, or topiramate monotherapy and underwent EEG and standardized language tests, it was noted that the seizure recurrence rates were 19.4% with lamotrigine, 21.7% with topiramate, and 11.4% with oxcarbazepine. Overall, the improvements in language and problem-solving performance in children with SeLECTS were greater for lamotrigine and oxcarbazepine than for topiramate (76).

A retrospective study evaluating the efficacy of lacosamide monotherapy in 18 children with SeLECTS showed that 39%, 67%, and 72% were seizure-free at 0 to 3, 4 to 6, and 7 to 12 months from treatment initiation, respectively (136).

As the seizures will almost invariably disappear in adolescence, therapy beyond that period is of little value. Relapse of seizures, however, may occur after premature antiepileptic drug withdrawal or poor response in 14% to 28% cases (84; 147). Studies suggest that the antiepileptic drugs can control the seizures but they neither improve the interictal EEG significantly nor shorten the years of spike persistence (94). Young age of seizure onset correlated with longer duration of EEG abnormalities (102). Pattern of spike disappearance did not significantly differ between the medication naïve group and antiepileptic drug-treated group (75). Predictors of poor response to initial antiseizure medications include younger age of seizure onset and history of febrile seizures (147).

Nonpharmacological treatment

Auditory stimulation during non-REM sleep suppresses spike activity and has been proposed as a nonpharmacological treatment of SeLECTS (95). Further studies are needed before this technique can be implemented in clinical practice.

Because sleep and epilepsy have an established bidirectional relationship, especially in SeLECTS, a UK-based, multicenter, open-label, randomized trial is currently underway to assess the effectiveness of behavioral sleep intervention in children with SeLECTS (01). The Changing Agendas on Sleep, Treatment and Learning in Epilepsy (CASTLE) Sleep-E trial compares clinical and cost effectiveness between standard care and standard care augmented with a novel, tailored, parent-led CASTLE Online Sleep Intervention. The latter consists of a self-paced, e-learning module for parents that supports parents in implementing general prevention techniques (eg, good sleep hygiene) and specific behavioral change techniques (eg, bedtime fading) relevant to their child’s sleep problems.

Outcomes

Overall, the long-term seizure outcome seems to be excellent, with less than 2% of cases developing absence seizures or generalized tonic-clonic seizures in adult life. Adults who had recovered from SeLECTS were not found to have negative outcomes in the fields of development, education, employment, and social adaptation (22). However, smaller studies report selective impairment, such as deficits in verbal perception and oromotor performance, in young adults with SeLECTS when followed for 10 years (179).

The data in children during the active years of epilepsy are variable and largely indicate the presence of cognitive and behavioral impairment. A systematic review and meta-analysis of 42 studies published prior to 2016 on cognitive functioning in children with SeLECTS concluded that they demonstrated significantly lower scores on neuropsychological tests across all cognitive factors compared to healthy controls (194). However, the possibility of a publication bias cannot be ruled out.

A natural history study of children with SeLECTS from a large, prospective, longitudinal cohort reported a high incidence of ADHD symptoms (18.3%) or learning difficulties (21.7%) before the diagnosis (155). New or persistent ADHD (20%), mood disorders (23.6%), learning difficulties (14.5%), and behavioral disorders (7.3%) were common after the diagnosis. At 9-year follow-up, performance on formal neuropsychological testing was comparable to population statistics and sibling controls (155). A systematic review of nine case-control and cohort studies on ADHD and ADHD-related neural networks in SeLECTS showed that the reported prevalence of ADHD in patients with SeLECTS was around 60% (07). The predictors of ADHD in SeLECTS were early age of seizure onset, long course of disease, and low intelligence scores (82). Comorbid ADHD has been associated with a higher degree of impairment in some domains of intellect (52).

Sudden unexpected death in epilepsy is a very rare outcome in SeLECTS and has been reported in three children with this syndrome among 189 decedents enrolled in the North American Sudden Unexpected Death in Epilepsy Registry (47). This seems to be an intriguing observation that needs further validation.

References

01: Al-Najjar N, Bray L, Carter B, et al. Changing agendas on Sleep, Treatment and Learning in Epilepsy (CASTLE) Sleep-E: a protocol for a randomised controlled trial comparing an online behavioural sleep intervention with standard care in children with Rolandic epilepsy. BMJ Open 2023;13(3):e065769. PMID 36898757
02: Alving J, Fabricius M, Rosenzweig I, Beniczky S. Ictal source imaging and electroclinical correlation in self-limited epilepsy with centrotemporal spikes. Seizure 2017;52:7-10. PMID 28926747
03: Ambrosetto G. Unilateral opercular macrogyria and benign childhood epilepsy with centrotemporal (rolandic) spikes. Epilepsia 1992;33:499-503. PMID 1592027
04: An O, Nagae LM, Aringazina A, Winesett SP. Comparative assessment of health-related quality of life with and without anticonvulsant therapy in patients with childhood epilepsy with centrotemporal spikes. J Int Med Res 2021;49(8):3000605211039805. PMID 34459274
05: Andrade R, García-Espinosa A, Machado-Rojas A, García-González ME, Trápaga-Quincoses O, Morales-Chacón LM. [A prospective, open, controlled and randomised study of clobazam versus carbamazepine in patients with frequent episodes of Rolandic epilepsy.] Rev Neurol 2009;49(11):581-6. PMID 19921623
06: Andrade-Machado R. Benign epilepsy with centro temporal spikes: Is there a thalamocortical network dysfunction present? Adding supporting evidence from SPECT imaging. Seizure 2020;80:143-4. PMID 32570171
07: Arico M, Arigliani E, Giannotti F, Romani M. ADHD and ADHD-related neural networks in benign epilepsy with centrotemporal spikes: a systematic review. Epilepsy Behav 2020;112:107448. PMID 32916583
08: Arzimanoglou A, Guerrini R, Aicardi J. Epilepsies characterized by partial seizures. In: Arzimanoglou A, Guerrini R, Aicardi J, editors. Aicardi´s epilepsy in children. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2004;114-75.
09: Asadi-Pooya AA, Forouzesh M, Eidi H, Mirzaghafour SE. Levetiracetam versus carbamazepine in treatment of rolandic epilepsy. Epilepsy Behav 2019;94:1-8. PMID 30884401
10: Bali B, Kull LL, Strug LJ, et al. Autosomal dominant inheritance of centrotemporal sharp waves in rolandic epilepsy families. Epilepsia 2007;48(12):2266-72. PMID 17662063
11: Baumer FM, Pfeifer K, Fogarty A, et al. Cortical excitability, synaptic plasticity, and cognition in benign epilepsy with centrotemporal spikes: a pilot TMS-EMG-EEG study. J Clin Neurophysiol 2020;37(2):170-80. PMID 32142025
12: Beaussart M. Benign epilepsy of children with rolandic (centrotemporal) paroxysmal foci. Epilepsia 1972;13:795-811. PMID 4509173
13: Bernardo HNSA, Miziara C, de Manreza MLG, Mansur LL. Oral dyspraxia in self-limited epilepsy with centrotemporal spikes: a comparative study with a control group. Arq Neuropsiquiatr 2021;79(12):1076-83. PMID 34816971
14: Besseling RM, Overvliet GM, Jansen JF, et al. Aberrant functional connectivity between motor and language networks in rolandic epilepsy. Epilepsy Res 2013;107(3):253-62. PMID 24210960
15: Beydoun A, Garofalo EA, Drury I. Generalized spike-waves, multiple loci, and clinical course in children with EEG features of benign epilepsy of childhood with centrotemporal spikes. Epilepsia 1992;33:1091-6. PMID 1464269
16: Bladin PF. The association of benign rolandic epilepsy with migraine. In: Andermann F, Lugaresi E, editors. Migraine and Epilepsy. Boston: Butterworths, 1987:145-52.
17: Borggraefe I, Bonfert M, Bast T, et al. Levetiracetam vs. sulthiame in benign epilepsy with centrotemporal spikes in childhood: a double-blinded, randomized, controlled trial (German HEAD Study). Eur J Paediatr Neurol 2013;17(5):507-14. PMID 23642492
18: Bouma PA, Bovenkerk AC, Westendorp RG, Brouwer OF. The course of benign partial epilepsy of childhood with centrotemporal spikes: a meta-analysis. Neurology 1997;48(2):430-7. PMID 9040734
19: Bray PF, Wiser WC. Evidence for a genetic etiology of temporal central abnormalities in focal epilepsy. N Engl J Med 1964;271:926-33. PMID 14197414
20: Callenbach PM, Bouma PA, Geerts AT, et al. Long term outcome of benign childhood epilepsy with centrotemporal spikes: Dutch Study of Epilepsy in Childhood. Seizure 2010;19(8):501-6. PMID 20688544
21: Camfield CS, Berg A, Stephani U, Wirrell EC. Transition issues for benign epilepsy with centrotemporal spikes, nonlesional focal epilepsy in otherwise normal children, childhood absence epilepsy, and juvenile myoclonic epilepsy. Epilepsia 2014;55 Suppl 3:16-20. PMID 25209080
22: Camfield CS, Camfield PR. Rolandic epilepsy has little effect on adult life 30 years later: a population-based study. Neurology 2014;82(13):1162-6. PMID 24562059
23: Caraballo R, Cersosimo R, Fejerman N. Idiopathic partial epilepsies with rolandic and occipital spikes appearing in the same children. J Epilepsy 1998;11:261-64.
24: Caraballo RH, Aldao Mdel R, Cachia P. Benign childhood seizure susceptibility syndrome: three case reports. Epileptic Disord 2011;13(2):133-9. PMID 21628136
25: Cavazzuti GB. Epidemiology of different types of epilepsy in school age children of Modena, Italy. Epilepsia 1980;21:57-62. PMID 6766394
26: Cerminara C, Coniglio A, El-Malhany N, Casarelli L, Curatolo P. Two epileptic syndromes, one brain: Childhood absence epilepsy and benign childhood epilepsy with centrotemporal spikes. Seizure 2012;21(1):70-4. PMID 22000044
27: Cheng W, Yang Y, Chen Y, et al. Anti-seizure medication treatment of benign childhood epilepsy with centrotemporal spikes: a systematic review and meta-analysis. Front Pharmacol 2022;13:821639. PMID 35359874
28: Ciumas C, Montavont A, Ilski F, et al. Neural correlates of verbal working memory in children with epilepsy with centro-temporal spikes. Neuroimage Clin 2020;8:102392. PMID 32927234
29: Clarke T, Baskurt Z, Strug LJ, Pal DK. Evidence of shared genetic risk factors for migraine and rolandic epilepsy. Epilepsia 2009;50(11):2428-33. PMID 19674062
30: Clemens B, Puskás S, Spisák T, et al. Increased resting-state EEG functional connectivity in benign childhood epilepsy with centro-temporal spikes. Seizure 2016;35:50-5. PMID 26794010
31: Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30(4):389-99. PMID 2502382
32: Covanis A, Lada C, Skiadas K. Children with Rolandic spikes and ictal vomiting: Rolandic epilepsy or Panayiotopoulos syndrome. Epileptic Disorders 2003;5(3):139-43. PMID 14684348
33: Curnow SR, Vogrin SJ, Barton S, Bailey CA, Harvey AS. Focal cortical hypermetabolism in atypical benign rolandic epilepsy. Epilepsy Res 2020;161:106288. PMID 32086099
34: Dai XJ, Liu H, Yang Y, Wang Y, Wan F. Brain network excitatory/inhibitory imbalance is a biomarker for drug-naive Rolandic epilepsy: a radiomics strategy. Epilepsia 2021a;62(10):2426-38. PMID 34346086
35: Dai XJ, Yang Y, Wang N, Tao W, Fan J, Wang Y. Reliability and availability of granger causality density in localization of Rolandic focus in BECTS. Brain Imaging Behav 2021b;15(3):1542-52. PMID 32737823
36: Dalla Bernardina B, Sgro V, Fejerman N. Epilepsy with centrotemporal spikes and related syndromes. In: Roger J, Bureau M, Dravet Ch, Genton P, Tassinari CA, Wolf P, editors. Epileptic syndromes in infancy, childhood and adolescence, 3rd ed. Eastleigh UK: John Libbey & Co Ltd, 2002:181-202.
37: Dalla Bernardina B, Sgro V, Fejerman N. Epilepsy with centrotemporal spikes and related syndromes. In: Roger J, Bureau M, Dravet Ch, Genton P, Tassinari CA, Wolf P, editors. Epileptic syndromes in infancy, childhood and adolescence, 4th ed. Montrouge UK: John Libbey & Co Ltd, 2005:203-25.
38: Danhofer P, Pejčochová J, Dušek L, Rektor I, Ošlejšková H. The influence of EEG-detected nocturnal centrotemporal discharges on the expression of core symptoms of ADHD in children with benign childhood epilepsy with centrotemporal spikes (BCECTS): a prospective study in a tertiary referral center. Epilepsy Behav 2018;79:75-81. PMID 29253678
39: Datta A, Sinclair DB. Benign epilepsy of childhood with rolandic spikes: typical and atypical variants. Pediatr Neurol 2007;36(3):141-5. PMID 17352945
40: Datta AN, Wallbank L, Mak JCH, Wong PKH. Clinical significance of incidental rolandic spikes in children with absence epilepsy. J Child Neurol 2019;34(11):631-8. PMID 31113278
41: De Negri M, Baglietto MG, Gaggero R. Benzodiazepine (BDZ) treatment of benign childhood epilepsy with centrotemporal spikes. Brain Dev 1997;19(7):506. PMID 9408602
42: de Marco P, Tassinari CA. Extreme somatosensory evoked potential (ESEP): an EEG sign forecasting the possible occurrence of seizures in children. Epilepsia 1981;22(5):569-75. PMID 6793354
43: Dedeoglu O, Altaş H, Yılmaz D, et al. Corpus callosum thickness: a predictive factor for the first drug efficiency of self-limited epilepsy with centrotemporal spikes (selects)? Epilepsy Res 2023;190:107072. PMID 36628885
44: Dimassi S, Labalme A, Lesca G, et al. A subset of genomic alterations detected in rolandic epilepsies contains candidate or known epilepsy genes including GRIN2A and PRRT2. Epilepsia 2014;55(2):370-8. PMID 24372385
45: Doose H, Baier WK, Ernst JP, Tuxhorn I, Volzke E. Benign partial epilepsy: treatment with sulthiame. Dev Med Child Neurol 1988;30:683-4. PMID 2906619
46: Doose H, Brigger-Heuer B, Neubauer B. Children with focal sharp waves: clinical and genetic aspects. Epilepsia 1997;38(7):788-96. PMID 9579906
47: Doumlele K, Friedman D, Buchhalter J, Donner EJ, Louik J, Devinsky O. Sudden unexpected death in epilepsy among patients with benign childhood epilepsy with centrotemporal spikes. JAMA Neurol 2017;74(6):645-9. PMID 28384699
48: Dryzalowski P, Jozwiak S, Franckiewicz M, Strzelecka J. Benign epilepsy with centrotemporal spikes - current concepts of diagnosis and treatment. Neurol Neurochir Pol 2018;52(6):677-89. PMID 30219586
49: Duan Y, Leng X, Liu C, et al. The correlation of ELP4-PAX6 with rolandic spike sources in idiopathic rolandic epilepsy syndromes. Front Neurol 2021;12:643964. PMID 33897599
50: Eeg-Olofsson O. Further genetic aspects in benign localized epilepsies in early childhood. In: Degen R, Dreifuss FE, editors. Benign localized and generalized epilepsies of early childhood. Epilepsy Research. Suppl 6. Amsterdam: Elsevier, 1992:117-9.
51: Engel J Jr. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: Report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001;42(6):796-803. PMID 11422340
52: Fang HB, Wang R, Chu LN, Feng YF, Bai RR, Guo FT. Cognitive impairment in children with benign childhood epilepsy with centrotemporal spikes and attention deficit hyperactivity disorder: a prospective study. Zhongguo Dang Dai Er Ke Za Zhi 2021; 23(8):791-6. PMID 34511167
53: Fejerman N. Atypical evolutions of benign partial epilepsies in children. Int Pediatr 1996;11(6):351-6.
54: Fejerman N. Benign focal epilepsies in infancy, childhood and adolescence. Rev Neurol 2002;34(1):7-18. PMID 11988887
55: Fejerman N, Caraballo R, Tenembaum SN. Atypical evolutions of benign localization-related epilepsies in children: are they predictable. Epilepsia 2000;41(4):380-90. PMID 10756401
56: Fejerman N, Caraballo RH, Dalla Bernardina B. Benign childhood epilepsy with centrotemporal spikes. In: Fejerman N, Caraballo RH, editors. Benign focal epilepsies in infancy, childhood and adolescence. Montrouge: John Libbey, 2007:77-113.
57: Fejerman N, Di Blasi AM. Status epilepticus of benign partial epilepsies in children: report of two cases. Epilepsia 1987;28:351-5. PMID 3113924
58: Filippini M, Boni A, Giannotta M, Gobbi G. Neuropsychological development in children belonging to BECTS spectrum: long-term effect of epileptiform activity. Epilepsy Behav 2013;28(3):504-11. PMID 23896351
59: Frauscher B, Bartolomei F, Kobayashi K, et al. High-frequency oscillations: the state of clinical research. Epilepsia 2017;58(8):1316-29. PMID 28666056
60: Fu C, Aisikaer A, Chen Z, Yu Q, Yin J, Yang W. Different functional network connectivity patterns in epilepsy: a rest-state fMRI study on mesial temporal lobe epilepsy and benign epilepsy with centrotemporal spike. Front Neurol 2021;12:668856. PMID 34122313
61: Fusco L, Trivisano M, Specchio N, Vigevano F. Rolandic epilepsy: an uncommon presentation with leg motor seizures. Epilepsia 2010;51(12):2488-91. PMID 21204813
62: Galer S, Urbain C, De Tiège X, et al. Impaired sleep-related consolidation of declarative memories in idiopathic focal epilepsies of childhood. Epilepsy Behav 2015;43:16-23. PMID 25546732
63: Galicchio S, Espeche A, Cersosimo R, et al. Self-limited epilepsy with centro-temporal spikes: a study of 46 patients with unusual clinical manifestations. Epilepsy Res 2021;169:106507. PMID 33296810
64: Garcia-Ramos C, Jackson DC, Lin JJ, et al. Cognition and brain development in children with benign epilepsy with centrotemporal spikes. Epilepsia 2015;56(10):1615-22. PMID 26337046
65: Gastaut Y. Un element deroutant de la semeiologie electroencephalographique: les pointes prerolandiques sans signification focale. Rev Neurol (Paris) 1952;87:488-90.
66: Gelisse P, Corda D, Raybaud C, Dravet C, Bureau M, Genton P. Abnormal neuroimaging in patients with benign epilepsy with centrotemporal spikes. Epilepsia 2003;44(3):372-8. PMID 12614393
67: Genizi J, Shamay-Tsoory SG, Shahar E, Yaniv S, Aharon-Perez J. Impaired social behavior in children with benign childhood epilepsy with centrotemporal spikes. J Child Neurol 2012;27(2):156-61. PMID 21868370
68: Gerstl L, Willimsky E, Remi C, Noachtar S, Borggrafe I, Tacke M. A systematic review of seizure-freedom rates in patients with benign epilepsy of childhood with centrotemporal spikes receiving antiepileptic drugs. Clin Neuropharmacol 2021;44(2):39-46. PMID 33605607
69: Gibbs EL, Gibbs FA. Good prognosis of mid-temporal epilepsy. Epilepsia 1960;1:448-53. PMID 13827913
70: Gibbs EL, Gillen HW, Gibbs FA. Disappearance and migration of epileptic foci in childhood. Am J Dis Child 1954;88:596-603. PMID 13206379
71: Gkampeta A, Fidani L, Clarimón J, et al. Association of brain-derived neurotrophic factor (BDNF) and elongator protein complex 4 (ELP4) polymorphisms with benign epilepsy with centrotemporal spikes in a Greek population. Epilepsy Res 2014;108(10):1734-9. PMID 25301525
72: Gregory DL, Wong PK. Topographical analysis of the centrotemporal discharges in benign Rolandic epilepsy of childhood. Epilepsia 1984;25:705-11. PMID 6510378
73: Guerrini R, Pellacani S. Benign childhood focal epilepsies. Epilepsia 2012;53 Suppl 4:9-18. PMID 22946717
74: Gu W, Chen J, Tian W, et al. Outcome analysis of children with rolandic discharges on EEG: a real-world study. Seizure 2020;82:105-8.** PMID 33059311
75: Han JY, Choi SA, Chung YG, et al. Change of centrotemporal spikes from onset to remission in self-limited epilepsy with centrotemporal spikes (SLECTS). Brain Dev 2020;42(3):270-6. PMID 31813543
76: Han MJ, Kim SJ. Effects of antiepileptic drugs on language abilities in benign epilepsy of childhood with centrotemporal spikes. J Clin Neurol 2018;14(4):523-9. PMID 30198231
77: Halasz P, Kelemen A, Clemens B, et al. The perisylvian epileptic network. A unifying concept. Ideggyogy Sz 2005;58(3-4):104. PMID 15884395
78: Heijbel J, Blom S, Rasmuson M. Benign epilepsy of childhood with centrotemporal EEG foci: a genetic study. Epilepsia 1975;16:285-93. PMID 807473
79: Hirsch LJ, Fong MWK, Leitinger M, et al. American Clinical Neurophysiology Society’s standardized critical care EEG terminology: 2021 version. J Clin Neurophysiol 2021;38(1):1-29. PMID 33475321
80: Hommet C, Billard C, Motte J, et al. Cognitive function in adolescents and young adults in complete remission from benign childhood epilepsy with centro-temporal spikes. Epileptic Disord 2001;3(4):207-16. PMID 11844716
81: Hu X, Tang J, Hua Y, Wang Y, Huang J. Evaluation of candidate genes in a Chinese cohort of atypical Rolandic epilepsy. Epileptic Disord 2021;23(4): 623-32. PMID 34279234
82: Huang C, Hu W, Tan G, Xu Y, Liu L. Clinical and electroencephalographic features of benign childhood epilepsy with centrotemporal spikes comorbidity with attention-deficit hyperactivity disorder in Southwest China. Epilepsy Behav 2021;111:107240. PMID 32603807
83: Ikemoto S, Hamano SI, Yokota S, Koichihara R, Hirata Y, Matsuura R. Enhancement and bilateral synchronization of ripples in atypical benign epilepsy of childhood with centrotemporal spikes. Clin Neurophysiol 2018;129(9):1920-5. PMID 30005220
84: Incecik F, Altunbasak S, Herguner OM, Mert G, Sahan D. Prognostic significance of failure of the initial antiepileptic drug in children with benign childhood epilepsy with centrotemporal spikes. Brain Dev 2015;37(1):66-70. PMID 24657010
85: Ito Y, Maki Y, Okai Y, et al. Involvement of brain structures in childhood epilepsy with centrotemporal spikes. Pediatr Int 2022;64(1):e15001. PMID 34562291
86: Jabbari K, Bobbili DR, Lal D, et al. Rare gene deletions in genetic generalized and Rolandic epilepsies. PLoS One 2018;13(8):e0202022. PMID 30148849
87: Jiang L, Ma X, Liu H, et al. Aberrant dynamics of regional coherence measured by resting-state fMRI in children with benign epilepsy with centrotemporal spikes (BECTS). Front Neurol 2021;12:712071. PMID 34975706
88: Jin G, Chen J, Du J, et al. Repetitive transcranial magnetic stimulation to treat benign epilepsy with centrotemporal spikes. Brain Stimul 2022;15(3):601-4. PMID 35427811
89: Kanemura H, Sano F, Ohyama T, Aihara M. Efficacy of levetiracetam for reducing rolandic discharges in comparison with carbamazepine and valproate sodium in rolandic epilepsy. Seizure 2018;62:79-83. PMID 30308427
90: Karalok ZS, Ozturk Z, Gunes A. Cortical thinning in benign epilepsy with centrotemporal spikes (BECTS) with or without attention-deficit/hyperactivity (ADHD). J Clin Neurosci 2019;68:123-7. PMID 31326285
91: Kidd SA, Lachiewicz A, Barbouth D, et al. Fragile X syndrome: a review of associated medical problems. Pediatrics 2014;134(5):995-1005. PMID 25287458
92: Kim SE, Lee JH, Chung HK, Lim SM, Lee HW. Alterations in white matter microstructures and cognitive dysfunctions in benign childhood epilepsy with centrotemporal spikes. Eur J Neurol 2014;21(5):708-17. PMID 24330132
93: Kim H, Yoo IH, Lim BC, et al. Averaged EEG spike dipole analysis may predict atypical outcome in benign childhood epilepsy with centrotemporal spikes (BCECTS). Brain Dev 2016;38(10):903-8. PMID 27329010
94: Kim H, Kim SY, Lim BC, et al. Spike persistence and normalization in benign epilepsy with centrotemporal spikes - implications for management. Brain Dev 2018;40(8):693-8. PMID 29754875
95: Klinzing JG, Tashiro L, Ruf S, Wolff M, Born J, Ngo HV. Auditory stimulation during sleep suppresses spike activity in benign epilepsy with centrotemporal spikes. Cell Rep Med 2021;2(11):100432. PMID 34841286
96: Kramer MA, Ostrowski LM, Song DY, et al. Scalp recorded spike ripples predict seizure risk in childhood epilepsy better than spikes. Brain 2019;142(5):1296-309. PMID 30907404
97: Kramer U, Nevo Y, Neufeld MY, Fatal A, Leitner Y, Harel S. Epidemiology of epilepsy in childhood: a cohort of 440 consecutive patients. Pediatr Neurol 1998;18(1):46-50. PMID 9492091
98: Kramer U, Zelnik N, Lerman-Sagie T, Shahar E. Benign childhood epilepsy with centrotemporal spikes: clinical characteristics and identification of patients at risk of multiple seizures. J Child Neurol 2002;17(1):17-9. PMID 11913563
99: Kwon H, Chinappen DM, Huang JF, et al. Transient, developmental functional and structural connectivity abnormalities in the thalamocortical motor network in Rolandic epilepsy. Neuroimage Clin 2022;35:103102. PMID 35777251
100: Larsson K, Eeg-Olofsson O. A population based study of epilepsy in children from a Swedish county. Eur J Paediatr Neurol 2006;10(3):107-13. PMID 16638642
101: Leal A, Calado E, Vieira JP, et al. Anatomical and physiological basis of continuous spike-wave of sleep syndrome after early thalamic lesions. Epilepsy Behav 2018;78:243-55. PMID 29133062
102: Lee EH, You SJ. Factors associated with electroencephalographic and clinical remission of benign childhood epilepsy with centrotemporal spikes. Brain Dev 2019;41(2):158-62. PMID 30205923
103: Lemke JR, Lal D, Reinthaler EM, et al. Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes. Nat Genet 2013;45(9):1067-72. PMID 23933819
104: Lerman P, Kivity S. Benign focal epilepsy of childhood. A follow-up study of 100 recovered patients. Arch Neurol 1975;32:261-4. PMID 804895
105: Lerman P, Kivity S. The benign partial nonrolandic epilepsies. J Clin Neurophysiol 1991;8:275-87. PMID 1918333
106: Lerman P, Lerman-Sagie T. Sulthiame revisited. J Child Neurol 1995;10:241-2. PMID 7642898
107: Li Q, Westover MB, Zhang R, Chu CJ. Computational evidence for a competitive thalamocortical model of spikes and spindle activity in rolandic epilepsy. Front Comput Neurosci 2021a;15:680549. PMID 34220477
108: Li Y, Chen J, Sun J, et al. Changes in functional connectivity in newly diagnosed self-limited epilepsy with centrotemporal spikes and cognitive impairment: an MEG study. Brain Behav 2022a;12(12):e2830. PMID 36408856
109: Li Y, Feng J, Zhang T, et al. Brain metabolic characteristics distinguishing typical and atypical benign epilepsy with centro-temporal spikes. Eur Radiol 2021b;31(12):9335-45. PMID 34050803
110: Li Y, Sun Y, Niu K, et al. The relationship between neuromagnetic activity and cognitive function in benign childhood epilepsy with centrotemporal spikes. Epilepsy Behav 2020a;112:107363. PMID 32858366
111: Li Y, Zhang T, Feng J, et al. Processing speed dysfunction is associated with functional corticostriatal circuit alterations in childhood epilepsy with centrotemporal spikes: a PET and fMRI study. Eur J Nucl Med Mol Imaging 2022b;49(9):3186-96. PMID 35199226
112: Li Z, Zhang J, Wang F, et al. Surface-based morphometry study of the brain in benign childhood epilepsy with centrotemporal spikes. Ann Transl Med 2020b;8(18):1150. PMID 33240999
113: Lima EM, Rzezak P, Guimaraes CA, et al. The executive profile of children with benign epilepsy of childhood with centrotemporal spikes and temporal lobe epilepsy. Epilepsy Behav 2017;72:173-7. PMID 28622557
114: Lima EM, Rzezak P, Montenegro MA, Guerreiro MM, Valente KDR. Social cognition in childhood epilepsy with centrotemporal spikes. Seizure 2020;78:102-8. PMID 32335335
115: Lischka A, Graf M. Benign rolandic epilepsy of childhood: topographic EEG analysis. Epilepsy Res Suppl 1992;6:53-8. PMID 1418492
116: Liu C, Song M, Wang J. Nightly oral administration of topiramate for benign childhood epilepsy with centrotemporal spikes. Childs Nerv Syst 2016;32(5):839-43. PMID 26984807
117: Liu MJ, Su XJ, Shi XY, et al. Clinical features of benign epilepsy of childhood with centrotemporal spikes in Chinese children. Medicine (Baltimore) 2017;96(4):e5623. PMID 28121917
118: Liu Z, Ye X, Zhang J, Wu B, Dong S, Gao P. Biallelic ADGRV1 variants are associated with Rolandic epilepsy. Neurol Sci 2022;43(2):1365-74. PMID 34160719
119: Loiseau P, Beaussart M. The seizures of benign childhood epilepsy with rolandic paroxysmal discharges. Epilepsia 1972;14:381-9. PMID 4521094
120: Loiseau P, Duche B, Cordova S, Dartigues JF, Cohadon S. Prognosis of benign childhood epilepsy with centrotemporal spikes. A follow-up study of 168 patients. Epilepsia 1988;29:229-35. PMID 3371279
121: Lombroso CT. Sylvian seizures and midtemporal spike foci in children. Arch Neurol 1967;17:52-9. PMID 6026172
122: Lu L, Xiong W, Zhang Y, Xiao Y, Zhou D. Propofol-induced refractory status epilepticus at remission age in benign epilepsy with centrotemporal spikes: a case report and literature review. Medicine (Baltimore) 2019;98(27):e16257. PMID 31277145
123: Luo T, Wang J, Zhou Y, et al. EMD-WOG-2DCNN based EEG signal processing for Rolandic seizure classification. Comput Methods Biomech Biomed Engin 2022;1-11. PMID 35044293
124: Matos M, Bara T, Clark S, Zeigelboim BS, Marques JM, Liberalesso PBN. Benign rolandic epilepsy of childhood and central auditory processing disorder: a noncasual neurophysiological association. Epilepsy Behav 2018;89:55-8. PMID 30384100
125: Metz-Lutz MN, Filippini M. Neuropsychological findings in Rolandic epilepsy and Landau-Kleffner syndrome. Epilepsia 2006;47(Suppl 2):71-5. PMID 17105467
126: Minami T, Gondo K, Yamamoto T, Yanai S, Tasaki K, Ueda K. Magnetoencephalographic analysis of rolandic discharges in benign childhood epilepsy. Ann Neurol 1996;39(3):326-34. PMID 8602751
127: Misiunas AVM, Meskauskas T, Samaitiene R. Algorithm for automatic EEG classification according to the epilepsy type: Benign focal childhood epilepsy and structural focal epilepsy. Biomed Sig Proc Control 2019;48:118-27.
128: Mitsudome A, Ohfu M, Yasumoto S, et al. The effectiveness of clonazepam on the rolandic discharges. Brain Dev 1997a;19(4):274-8. PMID 9187478
129: Mitsudome A, Ohu M, Yasumoto S, Ogawa A. Rhythmic slow activity in benign childhood epilepsy with centrotemporal spikes. Clin Electroencephalogr 1997b;28(1):44-8. PMID 9013050
130: Miziara CS, de Manreza ML, Mansur L, et al. Impact of benign childhood epilepsy with centrotemporal spikes (BECTS) on school performance. Seizure 2012;21(2):87-91. PMID 22221922
131: Monjauze C, Tuller L, Hommet C, Barthez MA, Khomsi A. Language in benign childhood epilepsy with centro-temporal spikes abbreviated form: Rolandic epilepsy and language. Brain Lang 2005;92(3):300-8. PMID 15721962
132: Nayrac P, Beaussart M. Les pointes-ondes prerolandiques: expression EEG tres particuliere. Etude electroclinique de 21 cas. Rev Neurol (Paris) 1958;99:201-6. PMID 13624406
133: Neng X, Xiao M, Yuanlu C, Qinyan L, Li S, Zhanyi S. Novel variant in CHRNA4 with benign childhood epilepsy with centrotemporal spikes and contribution to precise medicine. Mol Genet Genomic Med 2020;8(7):e1264. PMID 32342646
134: Northcott E, Connolly AM, Berroya A, et al. The neuropsychological and language profile of children with benign rolandic epilepsy. Epilepsia 2005;46(6):924-30. PMID 15946332
135: Oates S, Absoud M, Goyal S, et al. ZMYND11 variants are a novel cause of centrotemporal and generalised epilepsies with neurodevelopmental disorder. Clin Genet 2021;100(4):412-29. PMID 34216016
136: Okanishi T, Fujii Y, Sakuma S, et al. Lacosamide monotherapy for the treatment of childhood epilepsy with centrotemporal spikes. Brain Dev 2022;44(6):380-5. PMID 35241306
137: Oliveira EP, Neri ML, Capelatto LL, Guimarães CA, Guerreiro MM. Rolandic epilepsy and dyslexia. Arq Neuropsiquiatr 2014;72(11):826-31. PMID 25410447
138: Operto FF, Pastorino GMG, Mazza R, et al. Cognitive profile in BECTS treated with levetiracetam: a 2-year follow-up. Epilepsy Behav 2019;97:187-91. PMID 31252277
139: Otsubo H, Chitoku S, Ochi A, et al. Malignant rolandic-sylvian epilepsy in children: diagnosis, treatment, and outcomes. Neurology 2001;57(4):590-6. PMID 11524465
140: Overvliet GM, Aldenkamp AP, Klinkenberg S, Vles JSH, Hendriksen J. Impaired language performance as a precursor or consequence of Rolandic epilepsy? J Neurol Sci 2011;304(1-2):71-4. PMID 21377693
141: Ozgen Y, Gungor M, Kutlu M, Kara B. Clinical and electrophysiological predictors of behavioral disorders in patients with benign childhood epilepsy with centrotemporal spikes. Epilepsy Behav 2021;121(Pt A):108037. PMID 34058495
142: Pan A, Gupta A, Wyllie, E, Luders H, Bingaman W. Benign focal epileptiform discharges of childhood and hippocampal sclerosis. Epilepsia 2004;45(3):284-8. PMID 15009232
143: Panayiotopoulos CP. Benign childhood partial epilepsies: benign childhood seizure susceptibility syndrome. J Neurol Neurosurg Psychiatry 1993;56:2-5. PMID 8429319
144: Panayiotopoulos CP. Benign Childhood Partial Seizures and Related Epileptic Syndromes. London: John Libbey & Co Ltd, 1999.
145: Panayiotopoulos CP, Michael M, Sanders S, Valeta T, Koutroumanidis M. Benign childhood focal epilepsies: assessment of established and newly recognized syndromes. Brain 2008;131(Pt 9):2264-86. PMID 18718967
146: Parisi P, Paolino MC, Raucci U, Ferretti A, Villa MP, Trenite DK. “Atypical forms" of benign epilepsy with centrotemporal spikes (BECTS): how to diagnose and guide these children. A practical/scientific approach. Epilepsy Behav 2017;75:165-9.** PMID 28866336
147: Park YK, Eun SH, Eun BL, Byeon JH. Factors predicting poor response to initial therapy in benign childhood epilepsy with centrotemporal spikes (BCECTS). J Epilepsy Res 2015;5(2):70-4. PMID 26819938
148: Perlstein MA, Gibbs EL, Gibbs FA. The electroencephalogram in infantile cerebral palsy. In: Lennox WG, Merritt HH, Bamford TE, editors. Epilepsy (proceedings of the association for research in nervous and mental disease, research publications, vol 26). Baltimore: Williams & Wilkins, 1947:377-84.
149: Porat Rein A, Kramer U, Hausman Kedem M, Fattal-Valevski A, Mitelpunkt A. Early prediction of encephalopathic transformation in children with benign epilepsy with centro-temporal spikes. Brain Dev 2020;S0387-7604(20)30242-4.** PMID 32912653
150: Ramos IDSS. Coelho CVG, Ribeiro F, Lopes AF. Executive functioning in children with self-limited epilepsy with centrotemporal spikes: a systematic review and meta-analysis. Child Neuropsychol 2022; 28(1):30-60. PMID 34251988
151: Ramos LLP, Monteiro FP, Sampaio LPB, et al. Heterozygous loss of function of NR4A2 is associated with intellectual deficiency, rolandic epilepsy, and language impairment. Clin Case Rep 2019;7(8):1582-4. PMID 31428396
152: Rating D, Wolf C, Bast T. Sulthiame as monotherapy in children with benign childhood epilepsy with centrotemporal spikes: a 6-month randomized, double-blind, placebo-controlled study. Sulthiame Study Group. Epilepsia 2000;41(10):1284-8. PMID 11051123
153: Reinthaler EM, Dejanovic B, Lal D, et al. Rare variants in γ-aminobutyric acid type A receptor genes in rolandic epilepsy and related syndromes. Ann Neurol 2015;77(6):972-86. PMID 25726841
154: Robertson R, Langill L, Wong PK, Ho HH. Rett syndrome: EEG presentation. Electroencephalogr Clin Neurophysiol 1988;70:388-95. PMID 2460312
155: Ross EE, Stoyell SM, Kramer MA, Berg AT, Chu CJ. The natural history of seizures and neuropsychiatric symptoms in childhood epilepsy with centrotemporal spikes (CECTS). Epilepsy Behav 2020;103(Pt A):106437.** PMID 31645314
156: Salman R, Nasreddine W, Hannoun S, et al. Brain magnetic resonance imaging findings and brain volumetric differences in a large series of benign rolandic epilepsy. Neuroradiol J 2022;35(6):692-700. PMID 35467439
157: Sanlidag B, Koken OY, Temel EU, Arhan E, Aydin K, Serdaroglu A. Benign epilepsy with centrotemporal spikes: Is there a thalamocortical network dysfunction present? Seizure 2020;79:44-8. PMID 32416566
158: Santanelli P, Bureau M, Magaudda A, Gobbi O, Roger J. Benign partial epilepsy with centrotemporal (or rolandic) spikes and brain lesion. Epilepsia 1989;30(2):182-8. PMID 2494043
159: Sathyanarayana A, El Atrache R, Jackson M, et al. Nonlinear analysis of visually normal eegs to differentiate benign childhood epilepsy with centrotemporal spikes (BECTS). Sci Rep 2020;10(1):8419. PMID 32439999
160: Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017;58(4):512-21. PMID 28276062
161: Scheffer IE, Jones L, Pozzebon M, Howell RA, Saling MM, Berkovic SF. Autosomal dominant rolandic epilepsy and speech dyspraxia: a new syndrome with anticipation. Ann Neurol 1995;38(4):633-42. PMID 7574460
162: Sheth RD, Gutierrez AR, Riggs JE. Rolandic epilepsy and cortical dysplasia: MRI correlation of epileptiform discharges. Pediatr Neurol 1997;17(2):177-9. PMID 9367303
163: Shevell MI, Rosenblatt B, Watters GV, O’Gorman AM, Montes JL. “Pseudo-BECRS”: intracranial focal lesions suggestive of a primary partial epilepsy syndrome. Pediatr Neurol 1996;14(1):31-5. PMID 8652012
164: Shi XY, Wang G, Li T, et al. Identification of susceptibility variants to benign childhood epilepsy with centro-temporal spikes (BECTS) in Chinese Han population. EBioMedicine 2020;57:102840. PMID 32580138
165: Siripornpanich V, Visudtibhan A, Kotchabhakdi N, Chutabhakdikul N. Delayed cortical maturation at the centrotemporal brain regions in patients with benign childhood epilepsy with centrotemporal spikes (SLECTS). Epilepsy Res 2019;154:124-31. PMID 31129368
166: Smith AB, Bajomo O, Pal DK. A meta-analysis of literacy and language in children with rolandic epilepsy. Dev Med Child Neurol 2015;57(11):1019-26. PMID 26219529
167: Smith SDW, Smith AB, Richardson MP, Pal DK. Neurodevelopmental origins of self-limiting rolandic epilepsy: systematic review of MR imaging studies. Epilepsia Open 2021;6(2):310-22. PMID 34033258
168: Specchio N, Wirrell EC, Scheffer IE, et al. International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: position paper by the ILAE Task Force on Nosology and Definitions. Epilepsia 2022;63(6):1398-42. PMID 35503717
169: Spencer ER, Chinappen D, Emerton BC, et al. Source EEG reveals that Rolandic epilepsy is a regional epileptic encephalopathy. Neuroimage Clin 2022;33:102956. PMID 35151039
170: Sreenivasan A, Krishna R, Nair PP, Kasinathan A, Alexander A. Evaluation of auditory spectral resolution abilities in children with benign epilepsy with centrotemporal spikes using spectral temporally modulated ripple test. Epilepsy Behav 2021;114(Pt A):107620. PMID 33268014
171: Stephen J, Weir CJ, Chin RF. Temporal trends in incidence of Rolandic epilepsy, prevalence of comorbidities and prescribing trends: birth cohort study. Arch Dis Child 2020;105(6):569-74. PMID 31937568
172: Suo GH, Zheng YQ, Wu YJ, Tang JH. Effects of levetiracetam and oxcarbazepine monotherapy on intellectual and cognitive development in children with benign epilepsy with centrotemporal spikes. Acta Neurol Belg 2021;121(5):1265-73. PMID 33590471
173: Tacke M, Borggraefe I, Gerstl L, et al. Corrigendum to "EEG changes in rolandic epilepsy under treatment with levetiracetam and sulthiame" [Eur J Paediatr Neurol 21 (Suppl. 1) (June 2017) e97]. Eur J Paediatr Neurol 2017;21(6):e1. PMID 28797736
174: Tan HJ, Singh J, Gupta R, de Goede C. Comparison of antiepileptic drugs, no treatment, or placebo for children with benign epilepsy with centro temporal spikes. Cochrane Database Syst Rev 2014;2014(9):CD006779. PMID 25190506
175: Tang H, Wang Y, Hua Y, Wang J, Jing M, Hu X. Analysis of serial electroencephalographic predictors of seizure recurrence in Rolandic epilepsy. Childs Nerv Syst 2019;35(9):1579-83. PMID 31267183
176: Teixeira JM, Santos ME, Oom P. Oral language in children with benign childhood epilepsy with centrotemporal spikes. Epilepsy Behav 2020;111:107328. PMID 33027869
177: Tekgul H, Kanmaz S, Serin HM, Yilmaz S. Spike wave characteristics and temporal spike evolution on serial EEG in childhood epilepsy with centrotemporal spikes. Seizure 2021;87:75-80. PMID 33725524
178: Thorn EL, Ostrowski LM, Chinappen DM, et al. Persistent abnormalities in Rolandic thalamocortical white matter circuits in childhood epilepsy with centrotemporal spikes. Epilepsia 2020;61(11):2500-8. PMID 32944938
179: Tornhage M, Sandberg EN, Lundberg S. Oromotor, word retrieval, and dichotic listening performance in young adults with previous Rolandic epilepsy. Eur J Paediatr Neurol 2020;25:139-44. PMID 31866100
180: Tsai MH, Vears DF, Turner SJ, et al. Clinical genetic study of the epilepsy-aphasia spectrum. Epilepsia 2013;54(2):280-7. PMID 23294109
181: Tsai ML, Hung KL. Topographic mapping and clinical analysis of BCECS. Brain Dev 1998;20(1):27-32. PMID 9533557
182: Vadlamudi L, Kjeldsen M, Corey L, et al. Analyzing the etiology of benign rolandic epilepsy: a multicenter twin collaboration. Epilepsia 2006;47(3):550-5. PMID 16529620
183: Van Bogaert P, Wikler D, Damhaut P, Szliwowski HB, Goldman S. Cerebral glucose metabolism and centrotemporal spikes. Epilepsy Res 1998;29(2):123-7. PMID 9477144
184: van Klink NE, van 't Klooster MA, Leijten FS, Jacobs J, Braun KP, Zijlmans M. Ripples on rolandic spikes: a marker of epilepsy severity. Epilepsia 2016;57(7):1179-89. PMID 27270830
185: Vega YH, Smith A, Cockerill H, et al. Risk factors for reading disability in families with rolandic epilepsy. Epilepsy Behav 2015;53:174-9. PMID 26580214
186: Verrotti A, Casciato S, Spalice A, et al. Coexistence of childhood absence epilepsy and benign epilepsy with centrotemporal spikes: a case series. Eur J Paediatr Neurol 2017;21(3):570-5. PMID 28238620
187: Vinayan KP, Biji V, Thomas SV. Educational problems with underlying neuropsychological impairment are common in children with Benign Epilepsy of Childhood with Centrotemporal Spikes (BECTS). Seizure 2005;14(3):207-12. PMID 15797356
188: Wang F, Yin Y, Yang Y, et al. Connectome-based prediction of brain age in Rolandic epilepsy: a protocol for a multicenter cross-sectional study. Ann Transl Med 2021a;9(6):511. PMID 33850908
189: Wang P, Li Y, Sun Y, et al. Altered functional connectivity in newly diagnosed benign epilepsy with unilateral or bilateral centrotemporal spikes: a multi-frequency MEG study. Epilepsy Behav 2021b;124:108276. PMID 34547687
190: Watanabe K. Benign partial epilepsies. In: Wallace SJ, Farrell K, editors. Epilepsy in children. 2nd ed. London: Arnold, 2004:199-220.
191: Watemberg N, Afunevitz S, Ganelin-Cohen E, Mahajnah M. Clinical features at the time of diagnosis of benign epilepsy with centrotemporal spikes do not predict subsequent seizures. Pediatr Neurol 2018;88:36-9. PMID 30337131
192: Weglage J, Demsky A, Pietsch M, Kurlemann G. Neuropsychological, intellectual, and behavioral findings in patients with centrotemporal spikes with and without seizures. Dev Med Child Neurol 1997;39(10):646-51. PMID 9352724
193: Weir E, Gibbs J, Appleton R. Panayiotopoulos syndrome and benign partial epilepsy with centro-temporal spikes: a comparative incidence study. Seizure 2018;57:66-9. PMID 29571057
194: Wickens S, Bowden SC, D'Souza W. Cognitive functioning in children with self-limited epilepsy with centrotemporal spikes: a systematic review and meta-analysis. Epilepsia 2017;58(10):1673-85.** PMID 28801973
195: Wirrell EC, Camfield PR, Gordon KE, Dooley JM, Camfield CS. Benign rolandic epilepsy: atypical features are very common. J Child Neurol 1995;10(6):455-8. PMID 8576555
196: Wirrell EC, Grossardt BR, Wong-Kisiel LCL, Nickels KC. Incidence and classification of new-onset epilepsy and epilepsy syndromes in children in Olmsted County, Minnesota from 1980 to 2004: a population-based study. Epilepsy Res 2011;95(1-2):110-8. PMID 21482075
197: Wirrell EC, Hamiwka LD. Do children with benign rolandic epilepsy have a higher prevalence of migraine than those with other partial epilepsies or nonepilepsy controls. Epilepsia 2006;47(10):1674-81. PMID 17054690
198: Wu L, Yang X, Wang X, Yu S, Yang B. The attention networks in benign epilepsy with centrotemporal spikes: a long-term follow-up study. J Clin Neurosci 2021a;88:22-7. PMID 33992188
199: Wu L, Yang X, Zhang K, Wang X, Yang B. Impairment of eye emotion discrimination in benign childhood epilepsy with centrotemporal spikes: a neuropsychological study. Brain Behav 2021b;11(6):e02154. PMID 33942564
200: Wu Y, Fang F, Li K, et al. Functional connectivity differences in speech production networks in Chinese children with Rolandic epilepsy. Epilepsy Behav 2022;135:108819. PMID 35835716
201: Xiao F, An D, Deng H, Chen S, Ren J, Zhou D. Evaluation of levetiracetam and valproic acid as low-dose monotherapies for children with typical benign childhood epilepsy with centrotemporal spikes (BECTS). Seizure 2014;23(9):756-61. PMID 24998415
202: Xu Q, Hu Z, Yang F, et al. Resting state signal latency assesses the propagation of intrinsic activations and estimates anti-epileptic effect of levetiracetam in Rolandic epilepsy. Brain Res Bull 2020;162:125-31. PMID 32535220
203: Xu Z, Wang T, Cao J, Bao Z, Jiang T, Gao F. BECT spike detection based on novel EEG sequence features and LSTM algorithms. IEEE Trans Neural Syst Rehabil Eng 2021;29:1734-43. PMID 34428145
204: Yin Y, Wang F, Yang Y, Tian M, Gao L, Liu H. Abnormalities of hemispheric specialization in drug-naïve and drug-receiving self-limited epilepsy with centrotemporal spikes. Epilepsy Behav 2022;136:108940. PMID 36228484
205: You SJ, Kim DS, Ko TS. Benign childhood epilepsy with centro-temporal spikes (BCECTS): early onset of seizures is associated with poorer response to initial treatment. Epileptic Disord 2006;8(4):285-8. PMID 17150442
206: Zhang S, Tang J, Huang J, et al. Whole-brain dynamic resting-state functional network analysis in benign epilepsy with centrotemporal spikes. IEEE J Biomed Health Inform 2022;26(8):3813-21. PMID 35380976
207: Zhang Q, He Y, Qu T, et al. Delayed brain development of Rolandic epilepsy profiled by deep learning-based neuroanatomic imaging. Eur Radiol 2021;31(12):9628-37. PMID 34018056
208: Zhang XW, Dai RP, Cheng GW, Zhang WH, Long Q. Altered amplitude of low-frequency fluctuations and default mode network connectivity in high myopia: a resting-state fMRI study. Int J Ophthalmol 2020;13(10):1629-36. PMID 33078115

Contributors

All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.

Authors

K P Vinayan MD DM

Dr. Vinayan of the Amrita Institute of Medical Sciences has no relevant financial relationships to disclose.
See Profile
Arushi Gahlot Saini MD DM MNAMS

Dr. Saini of Postgraduate Institute of Medical Education and Research, Chandigarh, India, has no relevant financial relationships to disclose.
See Profile

Editor

Solomon L Moshé MD

Dr. Moshé of Albert Einstein College of Medicine has no relevant financial relationships to disclose.
See Profile

Former Authors

Natalio Fejerman MD (original author)

Patient Profile

Age range of presentation: 2 to 18 years
Sex preponderance: male>female, >1:1
Heredity: heredity may be a factor

autosomal dominant
Population groups selectively affected: none selectively affected
Occupation groups selectively affected: none selectively affected

ICD & OMIM codes

ICD-9: Localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures: 345.5
ICD-10: Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures: G40.1

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Self-limited epilepsy with centrotemporal spikes

Associated Disorders

Idiopathic generalized seizures

Differential Diagnosis

cerebral palsy
Rett syndrome
DEE-SWAS
EE-SWAS
structural focal epilepsies
- SeLFEs

Also Relevant

Benign infantile seizures
Epilepsy
Epilepsy with myoclonic-atonic seizures
Landau-Kleffner syndrome
Lennox-Gastaut syndrome
- Panayiotopoulos syndrome
- Parasomnias
- Sleep and epilepsy

Clinical Categories

Epilepsy & Seizures

Self-limited epilepsy with centrotemporal spikes

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Clinical features

Associated problems

Prognosis and complications

Biological basis

Etiology and pathogenesis

Pathophysiology

Epidemiology

Differential diagnosis

Confusing conditions

Associated or underlying disorders

Diagnostic workup

EEG

Brain MRI

Positron emission tomography

Functional MRI (fMRI)

Transcranial magnetic stimulation

Other investigational techniques

Management

Antiseizure medication treatment

Nonpharmacological treatment

Outcomes

Special considerations

Anesthesia

References

Contributors

Authors

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

Photosensitive occipital lobe epilepsy

Intermittent explosive disorder

Pyridoxine/P5P-dependent developmental epileptic encephalopathy

Reflex seizures

Anti-LGI1 encephalitis

Self-limited (familial) neonatal epilepsy

Epilepsy with auditory features

Alcohol withdrawal seizures

This is an article preview.
Start a Free Account
to access the full version.